Event Details

Thursday, 30 November 2017 - Thursday, 30 November 2017
12:00 pm - 12:30 pm
QBI Level 7 Auditorium
UQ Location:
Queensland Brain Institute (St Lucia)
Event category(s):

Event Contact

Ms Deirdre Wilson
3346 6300
Org. Unit:
Queensland Brain Institute

Event Description

Full Description:
Professor Rena Li - Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China

Title: 'Sex-specific targets to Alzheimer’s disease'

Reduction of sex hormone levels in menopausal women is associated with several major health risks, including an increased risk of Alzheimer’s disease (AD). Our previously published data showed that female AD patients express significantly less endogenous brain estrogen than age- and gender-matched normal controls. Depletion of endogenous estrogen causes an early onset of AD pathology and elevated beta-secretase (BACE1) enzymatic activity in a female transgenic animal model of AD. Inhibition of BACE1 is an attractive approach to prevent and delay AD progression. The interaction of estrogen and its receptors with specific DNA sequences, the so-called estrogen-responsive elements (EREs), constitutes a critical nuclear signaling pathway. We found an increase in BACE protein and activity levels in APP mice with a depletion of endogenous estrogen, suggesting a regulatory effect of estrogen on BACE in vivo. Two typical EREs and one half-site ERE have been identified in the BACE promoter. While no studies have been published on the effect of estrogen on BACE transcription activity yet, recent investigation showed that the half-site of the ERE or a typical ERE on promoter is responsible for transcriptional regulatory effects of estrogen on the somatostatin receptor and vascular endothelial growth factor. In this study, we investigated the estrogen effect on BACE1 promoter activity using the BACE promoter clones containing EREs. First, we investigated the effect of 17β-estradiol and genistein treatments on BACE1 promoter activity using a Luciferase reporter gene. Our data showed a significant downregulation of BACE1 promoter activity by 17β-estrodial and genistein treatments. We also used estrogen antagonists as well as gene knock down strategies to determine if the estrogen-induced downregulation of BACE1 promoter activity is estrogen receptor-dependent or independent. Furthermore, we mutated one or more of the half-size ERE(s) in the BACE1 promoter and found only specific EREs being responsible for the effects of estrogen on BACE1 transcriptional activity. Taken together, our results suggest that estrogen can downregulate BACE1 at the transcriptional level with a distinct ERE dependency.

Directions to UQ

Google Map:
To St Lucia Campus, UQ Ipswich, and UQ Gatton.

Event Tools

Share This Event

Print this Article Print

Print this Article Email

Share this Article Share

Rate This Event

Tweet This Event

Export This Event

Export calendar

Calendar Tools

Filter by Keywords/Dates

Featured Calendars

Subscribe via RSS